Primary information |
---|
sequence ID | Seq_1728 |
Peptide sequence | EEAPSLRPAPPPISGGG |
CancerPDF_ID | CancerPDF_ID849, CancerPDF_ID10233, |
PMID | 19795908,21805675 |
Protein Name | Fibrinogen beta chain,Fibrinogen beta chain |
UniprotKB Entry Name | FIBB_HUMAN,FIBB_HUMAN |
Fluid | Plasma,Urine |
M/Z | 816.41,1631.8263 |
Charge | 2,NA |
Mass (in Da) | NA,NA |
fdr | NA,NA |
Profiling Technique | LC-MS,MALDI-TOF |
Peptide Identification technique | MALDI-TOF/TOF,MALDI-TOF-MS |
Quantification Technique | LC-MRM (multiple reaction monitoring),NA |
Labelled/Label Free | Labelled,Label Free |
FDR | less than 7%,1 |
CancerPDF_ID | CancerPDF_ID849, CancerPDF_ID10233, |
p-Value | NA,NA |
Software | FlexAnalysis 3.0 and Biotools 3.0 software,NA |
Length | 17,17 |
Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Muscle-invasive bladder cancer |
Database | NCBI refseq Protein Database,SwissProt Database |
Modification | NA,NA |
Number of Patients | "42 normal, 26 patients",751 bladder cancer and 127 control |
Regulation | NA,Differentially expressed between cancer vs normal samples |
Validation | NA,Mann-Whitney tests and areas under receiver-operator characteristic |
Sensitivity | NA,NA |
Specificity | NA,NA |
Accuracy | NA,NA |
Peptide Atlas | PeptideAtlas |
IEDB | |